Corvel Corp CRVL
We take great care to ensure that the data presented and summarized in this overview for CORVEL CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CRVL
View all-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.93MShares$586 Million1.23% of portfolio
-
Black Rock Inc. New York, NY1.47MShares$448 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$331 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny669KShares$204 Million0.3% of portfolio
-
Dimensional Fund Advisors LP Austin, TX556KShares$169 Million0.04% of portfolio
-
State Street Corp Boston, MA357KShares$109 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY279KShares$84.8 Million0.06% of portfolio
-
Geode Capital Management, LLC Boston, MA244KShares$74.4 Million0.01% of portfolio
-
Boston Trust Walden Corp243KShares$73.9 Million0.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD221KShares$67.2 Million0.01% of portfolio
Latest Institutional Activity in CRVL
Top Purchases
Top Sells
About CRVL
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.
Insider Transactions at CRVL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 29
2024
|
Brandon O'Brien Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
377
-2.76%
|
$120,640
$320.0 P/Share
|
Aug 29
2024
|
Brandon O'Brien Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+5.48%
|
$34,800
$87.69 P/Share
|
Aug 23
2024
|
R Judd Jessup Director |
SELL
Open market or private sale
|
Direct |
2,500
-5.78%
|
$777,500
$311.6 P/Share
|
Aug 21
2024
|
Brandon O'Brien Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-13.33%
|
$314,000
$314.98 P/Share
|
Aug 12
2024
|
Michael G Combs CEO & President |
SELL
Open market or private sale
|
Direct |
2,473
-12.82%
|
$741,900
$300.99 P/Share
|
Aug 12
2024
|
Maxim Shishin Chief Information Officer |
SELL
Open market or private sale
|
Direct |
8,075
-62.16%
|
$2,414,425
$299.85 P/Share
|
Aug 12
2024
|
Maxim Shishin Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,075
+38.29%
|
$621,775
$77.93 P/Share
|
Aug 12
2024
|
Mark E. Bertels EVP - Risk Management Services |
SELL
Open market or private sale
|
Direct |
300
-25.91%
|
$89,700
$299.8 P/Share
|
Aug 12
2024
|
Mark E. Bertels EVP - Risk Management Services |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+20.58%
|
$26,400
$88.22 P/Share
|
Aug 08
2024
|
R Judd Jessup Director |
SELL
Open market or private sale
|
Direct |
2,131
-4.69%
|
$628,645
$295.21 P/Share
|
Aug 02
2024
|
Alan Hoops Director |
SELL
Open market or private sale
|
Indirect |
4,500
-8.71%
|
$1,350,000
$300.0 P/Share
|
Aug 02
2024
|
Alan Hoops Director |
SELL
Open market or private sale
|
Direct |
1,700
-15.32%
|
$510,000
$300.0 P/Share
|
Aug 02
2024
|
Brandon O'Brien Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
500
-1.6%
|
$150,000
$300.08 P/Share
|
Aug 02
2024
|
Brandon O'Brien Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.53%
|
$42,000
$84.84 P/Share
|
Aug 01
2024
|
Brandon O'Brien Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-1.96%
|
$92,718
$306.82 P/Share
|
Aug 01
2024
|
Brandon O'Brien Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+6.02%
|
$43,500
$87.69 P/Share
|
Aug 01
2024
|
Jennifer Yoss Vice President of Accounting |
SELL
Open market or private sale
|
Direct |
1,214
-43.98%
|
$364,200
$300.87 P/Share
|
Aug 01
2024
|
Jennifer Yoss Vice President of Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
300
+23.44%
|
$23,700
$79.49 P/Share
|
Aug 01
2024
|
Steven J Hamerslag Director |
SELL
Open market or private sale
|
Direct |
3,468
-3.11%
|
$1,054,272
$304.34 P/Share
|
Jul 29
2024
|
V Gordon Clemons Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.02%
|
$281,519
$307.82 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 70.7K shares |
---|---|
Other acquisition or disposition | 42K shares |
Bona fide gift | 4.92K shares |
Grant, award, or other acquisition | 70 shares |
Payment of exercise price or tax liability | 25.1K shares |
---|---|
Open market or private sale | 131K shares |
Bona fide gift | 34.9K shares |
Other acquisition or disposition | 42K shares |